Board Meeting

17 October 2024

Agenda

• Introductions to the shareholder report
• Business plan and 2024 year-end projections

  Sales report, financial and commercial forecasts, comparison with targets
• Team and structure

  Assessment of talent needs
• Administrator's variable compensation

  Presentation of proposals, voting, and decision-making
• Challenges

  ENISA (300K EUR loan, euribor+3.75%), Tender SESPA, close contracts, 2023 account correction, build and maintain the sales team, regulatory (MDD to MDR, FDA, Anvisa)
• Feedback and improvements for future meetings
• Future meeting dates

  29 Jan 2025, 26 Mar 2025, 25 Jun 2025, 29 Oct 2025
• Open floor